Concepedia

Katherine A. Kong

KA

Statistics

Publications

21

Citations

2.7K

H-Index

16

Active since

2007

Affiliations

Stanford University(Current)

Adaptive Biotechnologies (United States)

Center for Cancer Research

National Cancer Institute

Stanford Medicine

Katherine A. Kong is an author at Stanford University specializing in medicine, immunotherapy, and immunology.

Top concepts

Publications per year

2007–2022

21

Publications

21

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study

Mark Roschewski, Kieron Dunleavy, Stefania Pittaluga et al. · The Lancet Oncology · 2015 · 449 citations · Full text

, , +12

Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing

David M. Kurtz, Michael R. Green, Scott V. Bratman et al. · Blood · 2015 · 336 citations

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

Neha Korde, Mark Roschewski, Adriana Zingone et al. · JAMA Oncology · 2015 · 308 citations · Full text

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

Zinaida Good, Jay Y. Spiegel, Bita Sahaf et al. · Nature Medicine · 2022 · 224 citations · Full text

, , +10

1–5 of 21